CB1 antagonist 2

CAS No. 614726-85-1

CB1 antagonist 2( AM4113 )

Catalog No. M24614 CAS No. 614726-85-1

CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 29 In Stock
5MG 42 In Stock
10MG 69 In Stock
25MG 141 In Stock
50MG 245 In Stock
100MG 398 In Stock
200MG Get Quote In Stock
500MG 900 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CB1 antagonist 2
  • Note
    Research use only, not for human use.
  • Brief Description
    CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
  • Description
    CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3. Which inhibits CB1 in vivo with an IC50 of 25.5 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AM4113
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    CB1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    614726-85-1
  • Formula Weight
    380.66
  • Molecular Formula
    C17H12Cl3N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 60 mg/mL (157.62 mM; Need ultrasonic); H2O: < 0.1 mg/mL (insoluble)
  • SMILES
    Cc1c(-c(cc2)ccc2Cl)n(-c(ccc(Cl)c2)c2Cl)nc1C(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li, S. , et al. "4-methyl-1h-diaryl pyrazole derivatives and their uses as medicament." WO, WO2007121687 A1.
molnova catalog
related products
  • OMDM-5

    OMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM).

  • CB2R/FAAH?modulator-...

    CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting CB2R and FAAH, acting as a CB2R agonist (Ki = 10.8 nM) and FAAH inhibitor (IC50 = 6.2 μM), with a Ki value of 152.9 nM for CB1R.

  • Pravadoline

    Pravadoline is a cannabinoid receptor agonist. Pravadoline inhibited the PGs synthesis in mouse brain and displayed antinociceptive activity in rodents subjected to a variety of thermal, chemical, and mechanical nociceptive stimuli.